Business
- Operating in more than 150 + countries and 250+ customers worldwide.
- Widely focused on regulated markets and exports with 70+ commercial products.
- 20+ products in the R&D development and pipeline.
- Building CDMO capabilities and expansion.
- More focused on the oncology segment for the new product pipeline.
- Proven capability to handle Iron complex, HPAPI/Cytotoxic, Inorganic, and complex chemistry.
